A look inside prescription drugs and why they get removed from the market All medications released for public use must be approved by the United States Food and Drug Administration. In most cases, the drug goes through a rigorous testing process to insure that it is safe for the public. However, there have been cases … Read more
Many people have heard of class action lawsuits, but few are familiar with mass tort litigation. Although mass tort litigation is similar to class action lawsuits in that there are multiple cases combined into one, there are some differences. A class action lawsuit is a type of mass tort litigation. In order to reduce the … Read more
The decision to pursue a personal injury lawsuit is not always an easy one to make. However, when you or a loved one has suffered an injury due to another’s negligent conduct, you deserve to seek recovery as allowed by law. When it comes to any lawsuit, there are certain laws called “statutes of limitations” … Read more
February 14, 2013 The U.S. Food and Drug Administration (FDA) along with drug manufacturers, Qualitest Pharmaceuticals and Mylan Institutional, has announced the recall of several lots of hydrocodone bitartrate and acetaminophen tablets, USP 10 mg/500 mg. According to an FDA press release, the recall is being conducted due to defects in the medications that could lead … Read more
Reuters (1/14, Berkrot) reported that Johnson & Johnson has faulted the massive recalls at its McNeil manufacturing plant in Fort Washington, PA, on a series of problems, including lax cleaning procedures and poor documentation. An investigation by the company also found one product with an incorrect label, according to J&J. Kurt Bardella, a spokesman for … Read more
Folks, if you use any Johnson and Johnson over the counter products, you’ll want to read this. An article in the New York Times (Natasha Singer, 1/14/11) says that Johnson and Johnson is recalling about 43 million packages of Tylenol, Benadryl, Sudafed and Sinutab products from wholesalers because of past manufacturing practices like insufficient … Read more
The Los Angeles Times (10/27, Zajac) “Booster Shots” blog reported, “B. Braun Medical Inc., of Irvine on Wednesday announced a recall of seven lots of the anticoagulant heparin because of concerns they may be contaminated with trace amounts of oversulfated chondroitin sulfate, or OSCS, the same substance implicated in the 2008 heparin crisis that … Read more
The Wall Street Journal (9/27, Gryta) reports Amgen Inc. has recalled some lots of anemia drugs Epogen [epoetin alfa] and Procrit. The drugs sold by Johnson & Johnson have been recalled due to concerns they may contain glass flakes that are very thin. Amgen said the issue came about as a result of the interaction … Read more
If you use ProAmatine for blood pressure, Shire is taking it off the market. The AP (8/18, Perrone) reports, “Shire PLC said Tuesday it will pull” its blood-pressure drug ProAmatine (midodrine hydrochloride) “off the market” by the end of September “following warnings from federal regulators who said the drug has not been proven effective.” … Read more
SUBSCRIBE AND STAY UPDATED!
Footer Subscription Form
SOCIALS
